Don't Dismiss Acceleron Despite Its Recent Clinical Setback [The Motley Fool]
Acceleron Pharma Inc. (XLRN)
Last acceleron pharma inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.acceleronpharma.com/investor-relations
Company Research
Source: The Motley Fool
Don't Dismiss Acceleron Despite Its Recent Clinical Setback Getting new drugs to market can be a tough business. Acceleron Pharma ( NASDAQ:XLRN The drug showed initial promise for FSHD patients after it proved to increase muscle strength in patients who have disorders that impair muscle strength. Just over a year ago, in May 08, the company was given fast-track status by the FDA to expedite development and bring the drug to FSHD patients, who currently don't have any available drug therapies to inhibit muscle impairment. However, earlier this month, Acceleron announced that in phase trials Image Source: Getty Images Another path to market Acceleron still has high hopes for ACE-08 in treating patients with Charcot-Marie-Tooth disease (CMT), a neurological disorder that causes muscle loss. It's moving forward with phase clinical trials for this population. CMT is the most common inherited neurological disorder and affects one in ,00 people, or about 00,000 Americans. It's a progressiv
Show less
Read more
Impact Snapshot
Event Time:
XLRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XLRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XLRN alerts
High impacting Acceleron Pharma Inc. news events
Weekly update
A roundup of the hottest topics